NRC Health reported results for the quarter ended 2026 with revenue of $35.39M, up 4% from $34.04M a year earlier, and a net loss of ($3.28M) versus a loss of ($106K) in the prior-year quarter; diluted EPS was ($0.15) compared with ($0.01) a year ago.
Financial Highlights
| MetricCurrent quarterPrior year quarterYoY change | Revenue¹$35.39M$34.04M4% | Net income²($3.28M)($106K)(2997.2%) | Diluted EPS³($0.15)($0.01)(1400%) |
¹ Reported as “Revenue”. ² Reported as “Net income (loss)”. ³ Reported as “Earnings (loss) per share of common stock”.
Business Highlights
- Revenue growth of about 4% year-over-year was driven by higher recurring revenue from existing customers and additions of net new customers.
- The company introduced approximately $0.7M of contra‑revenue related to agent arrangements, reflecting increased third‑party solution facilitation.
- Total recurring contract value (TRCV) rose 11% YoY to $151.9M, indicating a stronger contracted recurring pipeline and improved revenue visibility.
- Management increased technology and delivery investments, including higher contractor, subscription and R&D costs; headquarters renovation completed in June 2025.
- Executive equity amendments and related transition costs raised stock‑based compensation and affected operating margins; these were characterized as non‑recurring items.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.